Ira J. Dunkel

13.4k total citations
248 papers, 7.7k citations indexed

About

Ira J. Dunkel is a scholar working on Genetics, Ophthalmology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ira J. Dunkel has authored 248 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 129 papers in Genetics, 101 papers in Ophthalmology and 64 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ira J. Dunkel's work include Glioma Diagnosis and Treatment (127 papers), Ocular Oncology and Treatments (100 papers) and Brain Metastases and Treatment (57 papers). Ira J. Dunkel is often cited by papers focused on Glioma Diagnosis and Treatment (127 papers), Ocular Oncology and Treatments (100 papers) and Brain Metastases and Treatment (57 papers). Ira J. Dunkel collaborates with scholars based in United States, Canada and United Kingdom. Ira J. Dunkel's co-authors include David H. Abramson, Scott E. Brodie, Y. Pierre Gobin, Jonathan L. Finlay, Brian P. Marr, Jasmine H. Francis, Sharon L. Gardner, Christopher M. Frank, Jonathan W. Kim and Marc K. Rosenblum and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ira J. Dunkel

241 papers receiving 7.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ira J. Dunkel United States 48 3.1k 3.0k 1.9k 1.7k 1.7k 248 7.7k
Murali Chintagumpala United States 52 765 0.2× 2.9k 1.0× 2.4k 1.3× 1.3k 0.7× 3.1k 1.8× 231 8.3k
David H. Abramson United States 56 9.6k 3.1× 1.5k 0.5× 2.6k 1.4× 796 0.5× 2.3k 1.4× 400 12.0k
Hervé J. Brisse France 38 718 0.2× 699 0.2× 1.2k 0.6× 1.7k 1.0× 905 0.5× 184 5.0k
Jonathan L. Finlay United States 63 685 0.2× 9.0k 3.0× 3.2k 1.7× 5.0k 2.9× 4.2k 2.5× 326 13.6k
Ibrahim Qaddoumi United States 33 786 0.3× 1.4k 0.5× 884 0.5× 771 0.4× 601 0.4× 161 3.5k
Jean Michon France 56 563 0.2× 814 0.3× 2.5k 1.3× 4.4k 2.6× 2.9k 1.8× 221 9.6k
Catherine A. Billups United States 48 372 0.1× 754 0.3× 2.5k 1.3× 1.2k 0.7× 2.0k 1.2× 165 6.0k
William M. Wara United States 67 464 0.1× 7.8k 2.6× 5.3k 2.8× 4.1k 2.4× 1.5k 0.9× 206 14.0k
C Kalifa France 47 239 0.1× 3.2k 1.1× 2.1k 1.1× 2.4k 1.4× 1.4k 0.8× 169 6.8k
Stewart Goldman United States 48 237 0.1× 3.0k 1.0× 1.2k 0.6× 2.1k 1.2× 2.4k 1.5× 178 6.7k

Countries citing papers authored by Ira J. Dunkel

Since Specialization
Citations

This map shows the geographic impact of Ira J. Dunkel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ira J. Dunkel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ira J. Dunkel more than expected).

Fields of papers citing papers by Ira J. Dunkel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ira J. Dunkel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ira J. Dunkel. The network helps show where Ira J. Dunkel may publish in the future.

Co-authorship network of co-authors of Ira J. Dunkel

This figure shows the co-authorship network connecting the top 25 collaborators of Ira J. Dunkel. A scholar is included among the top collaborators of Ira J. Dunkel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ira J. Dunkel. Ira J. Dunkel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Steinherz, Peter G., Tanya Trippett, Yasmin Khakoo, et al.. (2025). Phase II Study of Responses to Vaccination in Pediatric Cancer Survivors Following Standard‐of‐Care Non‐HSCT Chemotherapy. Pediatric Blood & Cancer. 72(5). e31611–e31611.
3.
Monje, Michelle, Tabitha Cooney, John Glod, et al.. (2023). Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047). Neuro-Oncology. 25(12). 2262–2272. 31 indexed citations
4.
Armstrong, Katherine, Audrey Mauguen, Emily K. Slotkin, et al.. (2022). Chemotherapy‐induced thrombocytopenia in pediatric oncology: Scope of the problem and opportunities for intervention. Pediatric Blood & Cancer. 69(10). e29776–e29776. 3 indexed citations
5.
Leary, Sarah, Lindsay Kilburn, J. Russell Geyer, et al.. (2021). Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026). Neuro-Oncology. 24(7). 1178–1190. 21 indexed citations
6.
Fuller, Christine, Olivia Campagne, Tong Lin, et al.. (2021). A Phase I and Surgical Study of Ribociclib and Everolimus in Children with Recurrent or Refractory Malignant Brain Tumors: A Pediatric Brain Tumor Consortium Study. Clinical Cancer Research. 27(9). 2442–2451. 17 indexed citations
7.
Vajapeyam, Sridhar, Douglas L. Brown, Catherine A. Billups, et al.. (2020). Advanced ADC Histogram, Perfusion, and Permeability Metrics Show an Association with Survival and Pseudoprogression in Newly Diagnosed Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium. American Journal of Neuroradiology. 41(4). 718–724. 13 indexed citations
8.
Hargrave, Darren, Éric Bouffet, Uri Tabori, et al.. (2019). Efficacy and Safety of Dabrafenib in Pediatric Patients with BRAF V600 Mutation–Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study. Clinical Cancer Research. 25(24). 7303–7311. 125 indexed citations
9.
Francis, Jasmine H., Sofia Haque, Ira J. Dunkel, et al.. (2019). Magnetic Resonance Imaging Screening for Trilateral Retinoblastoma. Ophthalmology Retina. 4(3). 327–335. 10 indexed citations
10.
Wang, Jiawan, Zhan Yao, Philip Jonsson, et al.. (2018). A Secondary Mutation in BRAF Confers Resistance to RAF Inhibition in a BRAF V600E-Mutant Brain Tumor. Cancer Discovery. 8(9). 1130–1141. 49 indexed citations
11.
Zarnegar, Sara, Benjamin H. Durham, Pallavi Khattar, et al.. (2017). Novel activating BRAF fusion identifies a recurrent alternative mechanism for ERK activation in pediatric Langerhans cell histiocytosis. Pediatric Blood & Cancer. 65(1). 17 indexed citations
12.
Ortiz, Michael V. & Ira J. Dunkel. (2015). Retinoblastoma. Journal of Child Neurology. 31(2). 227–236. 80 indexed citations
13.
Francis, Jasmine H., David H. Abramson, Y. Pierre Gobin, et al.. (2015). Efficacy and Toxicity of Second-Course Ophthalmic Artery Chemosurgery for Retinoblastoma. Ophthalmology. 122(5). 1016–1022. 35 indexed citations
14.
Francis, Jasmine H., David H. Abramson, Y. Pierre Gobin, et al.. (2014). Electroretinogram Monitoring of Dose-Dependent Toxicity after Ophthalmic Artery Chemosurgery in Retinoblastoma Eyes: Six Year Review. PLoS ONE. 9(1). e84247–e84247. 40 indexed citations
15.
Brodie, Scott E., Y. Pierre Gobin, Brian P. Marr, Ira J. Dunkel, & David H. Abramson. (2010). ERG Monitoring of Retinal Function After Super-Selective Intra-Arterial Chemotherapy for Retinoblastoma: 3-Year Results. Investigative Ophthalmology & Visual Science. 51(13). 3277–3277.
16.
Souweidane, Mark M., Peter Morgenstern, Paul J. Christos, et al.. (2009). INTRAOPERATIVE ARACHNOID AND CEREBROSPINAL FLUID SAMPLING IN CHILDREN WITH POSTERIOR FOSSA BRAIN TUMORS. Neurosurgery. 65(1). 72–78. 8 indexed citations
17.
Görlick, Richard, et al.. (2007). Impairments in antifolate transport are common in retinoblastoma tumor samples. Pediatric Blood & Cancer. 50(3). 573–576. 3 indexed citations
18.
Chantada, Guillermo, François Doz, Célia Beatriz Gianotti Antoneli, et al.. (2005). A proposal for an international retinoblastoma staging system. Pediatric Blood & Cancer. 47(6). 801–805. 153 indexed citations
19.
Zacharoulis, Stergios, David H. Abramson, & Ira J. Dunkel. (2005). More aggressive bone marrow screening in retinoblastoma patients is not indicated: The memorial Sloan-Kettering cancer center experience. Pediatric Blood & Cancer. 46(1). 56–61. 4 indexed citations
20.
Mason, Warren, Alfred Grovas, Samantha E. Halpern, et al.. (1998). Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors.. Journal of Clinical Oncology. 16(1). 210–221. 180 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026